Large-Scale Genome-wide association study identified Shared Genetic Risk SNPs Correlates in Epilepsy and Alzheimer's Disease
This large-scale genome-wide association study utilizing Mendelian randomization and UK Biobank data provides preliminary evidence that focal epilepsy with hippocampal sclerosis increases the risk of Alzheimer's disease and identifies the rs429358 variant in the APOE gene as a shared genetic risk factor linking the two conditions.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human brain is a vast, intricate network where electrical signals and chemical messages must flow in perfect harmony to sustain thought, memory, and movement. When this delicate balance is disrupted, the consequences can be severe, manifesting as distinct and often devastating conditions. Two such conditions are Alzheimer's disease, a progressive form of dementia that erodes memory and identity, and epilepsy, a disorder characterized by recurrent seizures caused by sudden, excessive electrical discharges in the brain. For decades, doctors and scientists have observed that these two conditions often appear together in the same people, suggesting a hidden link. While they were long studied as separate medical challenges, emerging evidence hints that they might share a common biological root, perhaps involving how the brain manages fats and proteins or how neurons communicate. Understanding this connection is crucial because if the same underlying mechanism drives both diseases, a treatment designed for one might help prevent or slow the other.
A team of researchers at West China Hospital of Sichuan University set out to find this shared root by looking directly at the genetic code. They conducted a massive study involving hundreds of thousands of people, analyzing their DNA to see if specific variations, known as single nucleotide polymorphisms, appeared more frequently in those with epilepsy, those with Alzheimer's, or both. The researchers focused on a specific type of epilepsy involving scarring in the hippocampus, a brain region vital for memory, and compared it against data from clinically diagnosed Alzheimer's cases. By using advanced statistical tools to sift through this mountain of genetic information, they were able to determine if a genetic tendency toward one condition actually increased the risk of the other, rather than just happening to occur together by chance.
The study revealed a potential connection, though with important caveats. The researchers found that a genetic predisposition to focal epilepsy with hippocampal sclerosis appeared to increase the likelihood of developing Alzheimer's disease. In their analysis, individuals with this specific genetic risk for epilepsy were nearly four times more likely to develop Alzheimer's compared to those without the risk. However, the researchers explicitly noted that this estimate was imprecise because it relied on only two genetic instruments, meaning the result should be viewed as preliminary evidence of a potential positive causal link rather than a definitive measurement. To confirm this, the team looked for specific genetic markers that acted as common denominators in both diseases. They identified a single, powerful genetic variant, known as rs429358, located in a gene called APOE on chromosome 19. This variant is already famous in the medical world for its strong association with Alzheimer's, but this study showed it also plays a significant role in epilepsy, where it approached genome-wide significance.
The power of this discovery lies in the sheer scale of the data and the precision of the methods used. The researchers analyzed genetic information from over 400,000 people in the UK Biobank, a massive repository of health data, alongside other large international datasets. They found that the specific genetic variant rs429358 was the only one that reached a high level of statistical significance in both the epilepsy and Alzheimer's groups simultaneously at the suggestive threshold. When they examined the region of the genome where this variant sits, they found that the genetic signals for both diseases overlapped almost perfectly. This means that the same genetic change is likely driving the risk for both conditions, rather than two separate genes happening to be near each other. The study further identified a group of five genes in this region, including APOE and its neighbors, that appear to be the primary suspects in this shared risk.
Digging deeper into what these genes actually do, the researchers found that they are heavily involved in how the body handles fats and cholesterol. The APOE gene, for instance, is a key player in transporting lipids, or fats, through the bloodstream and into the brain. The study suggests that when the genetic instructions for these lipid-handling genes are altered, it may disrupt the brain's ability to clear away toxic proteins or maintain the health of its nerve cells. This disruption could create an environment where both seizures and memory loss become more likely. The researchers noted that this shared mechanism involving lipid metabolism offers a unified explanation for why these two seemingly different diseases often travel together. It implies that the brain's struggle to manage its own chemical environment might be the common thread tying them together.
While the findings are robust, the researchers are careful to note that this is a starting point rather than a final answer. The study was limited to people of European ancestry, meaning the results might not apply equally to all populations, and the specific genetic variants identified need further testing in different groups. Additionally, while the genetic link is strong, the study does not yet prove exactly how these genes cause the diseases in a living person. However, the identification of this shared genetic risk provides a clear target for future research. It suggests that scientists could potentially develop new treatments that target the lipid metabolism pathways to protect against both epilepsy and Alzheimer's, offering hope for a dual approach to preventing these debilitating conditions. The discovery of this shared genetic signal transforms the way we view the relationship between seizures and dementia, moving from a coincidence of symptoms to a shared biological story waiting to be fully understood.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.